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ABSTRACT
Stem cell leukemia (Scl or Tal1) and lymphoblastic leukemia 1 (Lyl1)
encode highly related members of the basic helix-loop-helix family of
transcription factors that are co-expressed in the erythroid lineage.
Previous studies have suggested that Scl is essential for primitive
erythropoiesis. However, analysis of single-cell RNA-seq data of
early embryos showed that primitive erythroid cells express both
Scl and Lyl1. Therefore, to determine whether Lyl1 can function in
primitive erythropoiesis, we crossed conditional Scl knockout mice
with mice expressing a Cre recombinase under the control of the
Epo receptor, active in erythroid progenitors. Embryos with 20%
expression of Scl from E9.5 survived to adulthood. However, mice
with reduced expression of Scl and absence of Lyl1 (double
knockout; DKO) died at E10.5 because of progressive loss of
erythropoiesis. Gene expression profiling of DKO yolk sacs revealed
loss ofGata1 andmany of the known target genes of the SCL-GATA1
complex. ChIP-seq analyses in a human erythroleukemia cell line
showed that LYL1 exclusively bound a small subset of SCL targets
including GATA1. Together, these data show for the first time that
Lyl1 can maintain primitive erythropoiesis.
KEY WORDS: Primitive erythropoiesis, Transcription factors,
SCL (TAL1), LYL1, Mouse
INTRODUCTION
Hematopoietic stem cells (HSCs) give rise to all mature blood cells,
including red blood cells (RBCs), by a process known as definitive
hematopoiesis. However, the first hematopoietic cells emerge in
blood islands within the yolk sac at around embryonic day (E) 7.25
(Palis, 2014). This arrival of yolk sac-derived erythroid progenitors
gives rise to awave of maturing nucleated erythroid cells that sustain
the embryo between E9.5 and E12.5. Primitive erythrocytes can be
distinguished from adult RBCs in the circulation by the expression
of primitive globins and enucleation (Palis, 2014). In contrast,
definitive or adult erythrocytes, which express adult globins, are
first detected in the fetal bloodstream at around E11.5 and become
the major source of circulating RBCs beginning at E13.5 (Kingsley
et al., 2004).
A number of transcription factors (TFs) are known to be essential
for primitive erythropoiesis. Genetic knockout models demonstrate
that the TFs stem cell leukemia (Scl, also known as Tal1) and Gata1,
along with co-factors Lmo2 and Ldb1, are responsible for the
initiation of primitive erythropoiesis (Dore and Crispino, 2011).
These factors form a large multimeric complex in erythroid cells
that activates downstream targets for erythroid cell growth and
differentiation. The master regulatory role for this multimeric
complex is further emphasized by the ability of Scl, Lmo2 and
Gata1 to directly reprogram fibroblasts to erythroid cells that
resemble primitive erythroid progenitors in the yolk sac (Capellera-
Garcia et al., 2016).
Scl is a hematopoietic-specific basic helix-loop-helix (bHLH) TF
that is essential for the initial specification of hematopoiesis and
subsequent production of RBCs and platelets (Porcher et al., 2017).
It is known to form complexes with different binding partners to
regulate erythropoiesis (Tripic et al., 2009;Wadman et al., 1997). Its
bHLH region is highly homologous to that of the related family
member known as lymphoblastic leukemia 1 (Lyl1), which is also
expressed in the erythroid lineage (Visvader et al., 1991). During
hematopoietic development Scl is essential, with Scl knockout mice
dying in utero because of the absence of primitive erythropoiesis
and vascular defects (Robb et al., 1995; Shivdasani et al., 1995).
In contrast, Lyl1 knockout mice are viable, with a mild defect in
stress erythropoiesis (Capron et al., 2011). These distinct knockout
phenotypes can be explained by a crucial role for Scl in
hematopoietic specification that cannot be replaced by Lyl1 (Chan
et al., 2007). However, once hematopoiesis is established, Lyl1 can
compensate for the loss of Scl in HSCs to maintain their function.
It is only with the loss of both factors that there is rapid loss of
HSCs due to increased apoptosis (Souroullas et al., 2009). This
functional redundancy is consistent with genome-wide chromatin
immunoprecipitation (ChIP)-seq studies showing shared binding of
Scl and Lyl1 along with other crucial hematopoietic TFs in HSCs
(Beck et al., 2013; Chacon et al., 2014; Wilson et al., 2010).
The role for Scl in primitive erythropoiesis has been difficult to
delineate because of its crucial role in hematopoietic specification.
Nevertheless, two studies suggest that, unlike in adult HSCs, Lyl1
cannot adequately compensate for Scl in primitive erythropoiesis.
First, deletion of Scl after the formation of hematopoiesis using Scl
conditional knockout mice that express the Tie2Cre transgene
revealed the presence of circulating primitive erythrocytes, but
mice died at E13.5-14.5 with edema, hemorrhage and dysplastic
immature primitive erythroblasts (Schlaeger et al., 2005). A second
study overcame hematopoietic specification by generating Scl
knock-in mice that carry a germline DNA-binding mutation, in
which DNA binding is not required for specification of
hematopoiesis (Kassouf et al., 2008). Here, most embryos
succumbed at E14.5-17.5 with anemia and defects in erythroid
maturation. However, several observations raise the possibility thatReceived 4 January 2018; Accepted 28 August 2018
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Lyl1 can compensate for Scl in erythropoiesis. First, one quarter of
homozygous Scl DNA-binding mutant mice survive to adulthood
with a mild anemia (Kassouf et al., 2008). Second, loss of one Scl
allele leads to early perinatal death of Lyl1 knockout mice (Chan
et al., 2007). Finally, deletion of Scl in adult HSCs led to an acute
loss of erythropoiesis, but with recovery over subsequent weeks
(Hall et al., 2005).
To more clearly delineate the functional redundancy of Scl and
Lyl1 in erythropoiesis, we targeted Scl in erythropoiesis using
the erythroid-specific erythropoietin receptor Cre-recombinase
(EpoRCre) transgenic line (Heinrich et al., 2004), which is active
in yolk sac blood islands from E8.5 (Drogat et al., 2010). Using this
model, we show that markedly reduced expression of Scl in
committed erythroid progenitors from E8.5 was compatible with
embryonic development and resulted in only a mild normocytic
anemia in adult mice. However, when generated on a Lyl1 knockout
background, Scl/Lyl1 double knockout embryos died after E10.5
owing to the failure of primitive erythropoiesis. Gene expression
profiling and ChIP-seq suggested that this functional Scl
redundancy was due to shared Lyl1 and Scl target genes,
including the gene encoding the crucial factor Gata1. Thus,
reduced expression of Scl revealed a previously unsuspected role
for Lyl1 in primitive erythropoiesis.
RESULTS
Co-expression ofScl and Lyl1 in normal primitive progenitors
and erythroid cells
We first interrogated single-cell RNA-seq data obtained from E7.75
embryos to determine whether Scl and Lyl1 were co-expressed in
primitive blood progenitors and erythroid cells (Scialdone et al.,
2016). Four populations of cells could be defined by Scl and Lyl1
RNA expression in both blood progenitors and primitive erythroid
cells, with the majority of cells (166 of 271 cells, 61%) co-
expressing Scl and Lyl1 (Fig. 1A). In these cells, there was a weak
correlation between Scl and Lyl1 expression (Pearson correlation
coefficient r=0.17). Smaller numbers of cells expressing only Scl
(‘Scl-only’) (14%), cells expressing only Lyl1 (‘Lyl1-only’) (16%)
and cells apparently expressing neither (9%) were present. Overall,
read counts for cells that lacked Scl or Lyl1 transcripts were lower
than for cells that expressed Scl and/or Lyl1 (Fig. S1A), suggesting
that the apparent lack of expression might be explained by
expression below the sensitivity of sequencing. The distribution
of these sub-populations was different between blood progenitors
and primitive erythroid cells, with a significant increase in the
proportion of Scl-only and Lyl1-only cells in the primitive erythroid
cell population (χ2=47.2, P<0.00001; Fig. 1B).Gata1 and primitive
globin (Hbb-bh1) expression were not significantly different
between the four Scl;Lyl1-expressing subpopulations (Fig. 1C),
although gene set enrichment analysis (GSEA) of the erythroid cells
that lacked both Scl and Lyl1 revealed a reduction in the expression
of Gata1 targets and genes that are involved in heme metabolism
(Fig. S1B). Finally, erythroid cells without demonstrable Scl and
Lyl1 transcripts had a reduced expression of cell cycle-related E2F
target genes (Fig. 1D and Fig. S1C). Overall, single-cell gene
expression analysis demonstrated the co-expression of Scl and Lyl1
expression in the majority of blood progenitors and primitive
erythroid cells. Scl;Lyl1 non-expressing cells were also identified,
but these may be explained by technological factors such as low
read counts for TFs that are expressed at low levels.
Markedly reduced expression of Scl during development is
sufficient for survival to adulthood
To determine the role of Scl in developmental erythropoiesis, we
crossed Scl conditional knockout mice (SclcKO) (Hall et al., 2003)
with EpoRCre mice, which express Cre after the initiation of
erythropoiesis from E8.5 (Drogat et al., 2010). Mating of EpoRCre
mice with EYFP reporter mice confirmed the presence of Cre
activity from the colony forming unit-erythroid stage (CFU-e)
onwards (Fig. S2). Deletion of Scl from E8.5 did not lead to
embryonic lethality: EpoRCreSclcKOmice (ESclcKO) were born at
the expected Mendelian ratio with a mild normocytic anemia
(Table 1). Analysis of whole yolk sacs from ESclcKO E9.5 embryos
demonstrated a reduced but detectable (19%) expression of Scl
(Fig. 2A). Expression of Scl in the absence of Lyl1 was not
increased. Fluorescence-activated cell sorting (FACS) analysis of
adult ESclcKO bone marrow demonstrated an increase in immature
Ter119loCD71+ erythroblasts (Fig. 2B) similar to that seen in
MxCreSclcKO mice (Hall et al., 2005). As expected, absence of
Lyl1 had no effect on steady state bone marrow erythropoiesis
(Fig. 2B). Similar to the ESclcKO E9.5 embryos, quantitative
Fig. 1. Scl and Lyl expression in wild-type
embryonic-derived progenitors and RBCs. (A) Scl
and Lyl1 expression [log2 counts per million (CPM)] in
single-cell blood progenitors and primitive erythroid cells
from E7.75 wild-type embryos (GSE74994). The
numbers in parentheses designate the numbers of
progenitor and erythroid cells in the four subpopulations,
respectively: Scl+Lyl1+; Scl+Lyl1−; Scl−Lyl1+ and
Scl−Lyl1−. Note the Scl−Lyl1− population is designated
by a single dot as they are overlaid. (B) Proportion of the
four subpopulations in blood progenitors (Prog) and
primitive erythroid cells (Ery). (C) Expression of
embryonic globin (Hbb-bh1) and Gata1 in the four
subpopulations shown as a box plot with median.
Whiskers show maximum and minimum values.
(D) GSEA analysis of differentially expressed genes
between cells expressing Scl and Lyl1 and cells not
expressing Scl and Lyl1 that demonstrates enrichment in
E2F gene targets.
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real-time PCR (qPCR) of sorted bone marrow Ter119hiCD71+
erythroblasts demonstrated a 20% residual expression of SclmRNA
in ESclcKO but no compensatory increase in Lyl1 expression
(Fig. 2C). The reduced expression of Scl in ESclcKO erythroid cells
had no effect on the growth of CFU-e in vitro (Fig. 2D). Taken
together, these results show that the significantly reduced
expression of Scl after E8.5 was compatible with embryonic
survival to adulthood.
Lyl1 can substitute for Scl in primitive erythropoiesis
As previously described (Capron et al., 2011), mice that lack Lyl1
(Lyl1KO) had a mild RBC phenotype with macrocytosis (Table 1).
We bred ESclcKO mice with Lyl1KO mice to determine whether
Lyl1 was providing the redundancy in primitive erythropoiesis
with reduced Scl expression. Consistent with this hypothesis, mice
with the loss of both Scl and Lyl1 in erythropoiesis did not survive
to weaning. Timed mating identified pale embryos from E10.5
onwards (Fig. 3A), with loss of the fetal heartbeat by E11.5 and
complete absence of ESclcKO;Lyl1KO (DKO) embryos by E12.5
(Table 2). Histological sections of E10.5 DKO yolk sacs
demonstrated a decrease in the number of nucleated RBCs
(Fig. 3B). Benzidine staining of DKO yolk sac cells showed the
progressive loss of benzidine+ cells from E10.5, with the reduced
intensity of staining indicative of reduced heme (Fig. 3C,D).
To assess the erythroid compartment of the DKO embryos in
more detail, E10.5 yolk sacs were digested with collagenase and
single-cell suspensions generated for FACS analysis (Fig. 3E).
ESclcKO erythroblasts had a mildly reduced expression of Ter119, a
known transcriptional target of Scl (Kassouf et al., 2008; Lahlil
et al., 2004). In contrast, DKO embryos had no detectable
expression of surface Ter119. Therefore, normal expression of
either Scl or Lyl1 was required to maintain primitive erythropoiesis
and survival beyond E10.5.
Scl and Lyl1 regulate Gata1 and shared downstream targets
in primitive erythropoiesis
To gain insight into the regulation of primitive erythropoiesis by Scl
and Lyl1, we performed RNA-seq analysis on cells from E9.5 yolk
sacs, a time before any significant loss of benzidine+ erythroblasts in
DKO embryos (Fig. 3D). Markedly reduced, but not absent,
expression of the lox-P-flanked exon 5 of Scl (10% of wild-type
levels) was observed in ESclcKO yolk sacs (Fig. 4A and Fig. S3).
DKO yolk sacs also had markedly reduced expression of Scl, apart
from one yolk sac in which expression was only reduced by ∼50%
(Fig. S3). Residual expression of Scl might be explained by either
incomplete deletion in primitive erythropoiesis or expression in
endothelial cells, given that the expression analysis was performed
using whole yolk sacs that contain endothelial cells. As expected for
a constitutive knockout, Lyl1 mRNA was essentially absent in
Lyl1KO and DKO yolk sac cells (Fig. S3). Overall, the RNA-seq
analysis at E9.5 confirmed the absence of Lyl1 expression and
the markedly reduced, but not absent, expression of Scl exon 5 in the
knockout yolk sacs.
Multi-dimensional scaling using the 500 most differentially
regulated genes confirmed the clustering of samples according to
genotype (Fig. S4). Using a false discovery rate of 0.01, 156 genes
were differentially expressed (32 up and 124 down) in ESclcKO
Table 1. RBC parameters of adult mice
Parameter Wild-type EpoRCreSclcKO Lyl1KO P*
RBCs×1012/l 10.37±0.51 8.44±0.28* 9.79±0.44 0.01
Hemoglobin, g/dl 15.13±0.65 12.03±0.53* 14.83±0.64 0.004
Hematocrit (%) 48.20±2.40 39.03±2.06* 48.02±2.20 0.02
MCV, fl 46.31±0.48 45.68±0.98 49.3±0.56* 0.01
MCH, pg 14.54±0.16 14.03±0.25 15.41±0.17* 0.02
MCHC, g/dl 31.30±0.41 30.68±0.37 31.16±0.34 ns
RDW (%) 19.08±0.45 20.61±0.33* 18.95±0.22 0.01
Mean±s.e.m. calculated from 10 mice/genotype. MCH, mean corpuscular
hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV,
mean cell volume; RDW, RBC distribution width. *P-value calculated versus
wild type using one-way ANOVA with Tukey’s multiple comparison; P<0.05
considered significant.
Fig. 2. Erythropoiesis in single knockout mice. (A) Expression of Scl in E9.5 yolk sacs from wild-type (WT), EpoRCreSclf/f (ESclcKO) and Lyl1KO embryos.
(B) Representative FACS plots of WT, ESclcKO and Lyl1KO adult bone marrow stained with Ter119 and CD71 showing gates that define pro-erythroblasts
(CD71+Ter119lo), intermediate erythroblasts (CD71+Ter119+) and late erythroblasts (CD71−Ter119+). (C) Expression of Scl (left panel) and Lyl1 (right panel) in
FACS-isolated intermediate erythroblasts from adult mice. (D) The number of erythroid colony forming units (CFU-erythroid) per 50,000 bone marrow cells from
adult WT and ESclcKO mice. Data are mean±s.e.m. of three mice for each genotype.
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yolk sacs and 310 genes (101 up and 209 down) in Lyl1KO yolk sacs
(Fig. 4B and Table S1). GSEA showed downregulation of collagen
and extracellular matrix genes in single knockouts (Fig. 4C and
Fig. S4B). In yolk sacs from DKO embryos, 568 genes were
differentially expressed (168 up and 400 down), with more than
70% (401) unique to the DKO embryos (Fig. 4B). Analysis of DKO
cells also revealed a reduction in extracellular matrix organization
genes, which was further reduced compared with Lyl1KO but not
with ESclcKO cells (Fig. S4B). Unlike single knockouts, GSEA
analysis of DKO cells revealed the downregulation of genes that are
involved in heme metabolism (Fig. 4D,E). Of note, there was no
evidence of increased apoptosis genes in DKO cells (Fig. S4C).
Gata1 is a known target gene of Scl,with both factors participating in
a multimeric complex regulating erythropoiesis (Tripic et al., 2009;
Wadman et al., 1997). Gata1 expression was normal in ESclcKO cells
but reduced twofold in Lyl1KO cells and, most markedly, reduced
tenfold in DKO cells (Fig. 4F). Consistent with the loss of Gata1, the
expression of reported targets of the SCL-GATA1 complex, including
Kruppel-like factor 1 (Klf1), FOG family member 1 (Zfpm1) and
transferrin receptor (Tfrc) were reduced in DKO cells (Fig. 4G).
However, loss of both Scl and Lyl1 did not affect the expression of
genes encodingothermembers of theSCL-GATA1complex, including
Tcf3 (also known as E47), Ldb1, Lmo2 and the co-repressor Cbfa2t3
(also known as Eto-2) (Fig. S5A). Of note, expression of both Gata2
and Runx1 was increased in DKO cells (Fig. S5B).
Previous studies have implicated a role for Gata1 in survival of
erythroblasts (Weiss and Orkin, 1995), which might explain the loss
of benzidine+ erythroblasts between E9.5 and E10.5 (Fig. 2D).
However, p53 target genes were not increased in DKO cells
(Fig. S6A). In contrast, and similar to wild-type E7.75 primitive
erythroid cells with no detectable Scl and Lyl1 transcripts (Fig. 1D),
there was a reduction in E2F target genes in DKO cells (Fig. S6B
and S6C). In summary, gene expression analyses before the loss of
benzidine-staining cells in E9.5 yolk sac demonstrated the reduced
expression of Gata1 and its targets in DKO cells.
Fig. 3. Embryos lacking Lyl1 and reduced Scl die owing to failure of erythropoiesis. (A) Representative E10.5 EpoRCret/+Sclf/fLyl1k/k embryo (DKO)
showing pale embryo compared with a Lyl1 heterozygous (Lyl1Het) embryo and single knockout embryos (ESclcKO and Lyl1KO). (B) Benzidine staining of
yolk sac cells demonstrating the decreased number of globin-expressing cells (orange) in E10.5 DKO embryos. (C) Representative FACS profiles of wild-type,
ESclcKO, Lyl1KO and DKO E10.5 yolk sacs. (D) Proportion of erythroid fractions are mean±s.e.m. of four mice for each genotype. (E) Number of benzidine+
cells per high-power field (HPF) from wild-type (WT), ESclcKO, Lyl1KO and DKO embryos from E9.5 to E12.5. Data are mean±s.e.m. of four mice for each
genotype.
Table 2. Numbers of DKO embryos
Embryonic day Total embryos Expected Observed
E9.5 45 12 14
E10.5 38 9 8
E11.5 25 6 8
E12.5 22 6 0
E13.5 20 5 0
E15.5 8 2 0
Numbers of EpoRCreSclcKO;Lyl1KO (DKO) embryos generated from
EpoRCreSclcKO;Lyl1 heterozygous mice mated with SclcKO;Lyl1KO mice.
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LYL1 binds a small subset of SCL targets
We used ChIP to identify the common binding targets of Scl and
Lyl1 in erythropoiesis. None of the commercially available
anti-Lyl1 antibodies were able to pull down mouse Lyl1 and
therefore we used the human erythroleukemia cell line K562 for
ChIP experiments to compare SCL and LYL1 DNA binding.
Overall, 23,547 SCL- and 1409 LYL1-binding peaks were
identified in the K562 genome (Fig. 5A and Table S2). Most
strikingly, 1405 (99.7%) of the LYL1-binding sites were also bound
by SCL, indicating that LYL1 almost exclusively binds a small
subset of SCL targets. Importantly, overlapping binding was seen at
the GATA1 gene locus (Fig. 5B) as well as at loci of other erythroid-
specific TFs (KLF1 and ZFPM1), heme synthetic enzymes and
RBC membrane proteins (Fig. S7A-C), and at the locus control
Fig. 4. RNA-seq analysis of E9.5 yolk sacs. (A) Expression of exon 5 of Scl in wild-type (WT), ESclcKO, Lyl1KO and DKO E9.5 yolk sacs. Data are mean±
s.e.m. of three mice for each genotype. (B) Venn diagram showing numbers of differentially expressed genes in ESclcKO, Lyl1KO and DKO E9.5 yolk sacs
compared with wild-type E9.5 yolk sacs using a false discovery rate of 0.01. (C) GSEA of genes involved in extracellular matrix organization in ESclcKO
cells. (D) GSEA of genes involved in heme metabolism in DKO cells. (E) Heat map showing expression of leading edge heme-related genes from panel C.
(F) qPCR of Gata1 in WT, ESclcKO, Lyl1KO and DKO cells. Expression normalized for Hprt and expressed relative to WT. Data are mean±s.e.m. of three
pools of yolk sacs for each genotype. *P<0.05 (Student’s t-test). (G) GSEA of Gata1 target genes in DKO cells with leading edge genes listed.
Fig. 5. LYL1 binds a small subset of SCL targets
including GATA1. (A) Venn diagram showing numbers
of common and unique binding peaks for SCL and LYL1
in the human erythroid leukemia cell line, K562. (B) Read
peak plot for ChIP-seq reads in K562 cells displayed in
the UCSC genome browser (genome.ucsc.edu) shows
overlapping binding of SCL and LYL1 near the GATA1
gene. (C) De novo motif discovery of LYL1 and SCL-
binding sites in K562 cells has identified significant
enrichment for the GATA, E-BOX, RUNX and ETSmotifs.
(D) Venn diagram showing numbers of shared and
unique binding peaks for SCL, LYL1, GATA1 and RUNX1
in K562 cells.
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region of the β-globin locus. The shared SCL- and LYL1-binding
sites were enriched for GATA1, E-BOX, RUNX and ETS motifs
(Fig. 5C). Furthermore, the majority of SCL and LYL1 shared
binding sites (1157/1405, 82%) were also occupied by GATA1 with
or without RUNX1 (Fig. 5D and Table S2). In summary, genome-
wide ChIP-seq analysis in K562 human erythroleukemic cells
shows that LYL1 binds a small subset (6%) of SCL targets that are
also bound by GATA1.
Previous studies using mice with a mutant form of Scl that does
not bind DNA (Scl DNA-binding mutant mice) have identified 594
genome regions (∼20% of all Scl-binding sites) that could bind in
the absence of direct Scl binding (Kassouf et al., 2010). To test the
possibility that LYL1 might be able to replace SCL at these target
regions, LYL1 and SCL common binding sites in K562 cells
(1405 regions) were compared with Scl-binding regions in the Scl
DNA-binding mutant mice (GSE18720). These 594-mouse genome
regions were mapped to 494 human-genome regions. Intersection
with the 1405 SCL and LYL1 shared binding sites identified in
K562 cells revealed a significant overlap of 83 common sites (Table
S3, z-score 25.96). Importantly, this overlap was more significant
than the intersection of the remaining 2400 (80%) SCL-dependent
binding sites with the same 1405 SCL and LYL1 shared binding
sites (Table S3, z-score 12.61). Pathway analysis of the 75 nearest
genes showed enrichment for embryonic hematopoiesis (Table S3)
that included Gata1, Runx1, Lmo2 and Gfi1. Therefore, the
previously identified SCL-binding sites that are independent of
direct SCL binding are enriched for LYL1-binding sites.
Scl and Lyl1 directly regulate Gata1 and its targets
To identify the functionally relevant shared Scl- and Lyl1-binding
targets, we integrated ChIP-seq and RNA-seq data. We mapped
the 1405 shared targets from K562 to 1403 mouse homologs
(Table S2). Taken together, we found that 127 genes were
differentially expressed in either single knockout or DKO mice.
Of these, the majority (80 genes, 63%) were differentially expressed
in the DKOmice only (Fig. 6A, Fig. S8 and Table S2). The majority
of these shared SCL and LYL1 targets were repressed (59 genes,
74%) including Gata1, Klf1 and Zpfm1, whereas the remaining
genes (21 genes, 26%) were upregulated and included Runx1. We
confirmed these findings using Scl ChIP-seq data obtained from
purified hematopoietic progenitors derived from mouse embryonic
stem cells (Goode et al., 2016). Overall, Scl-binding sites could be
mapped to 3061 genes (Table S2). Intersection of these genes with
our mouse expression data from single knockout or DKO yolk sacs
identified 114 genes that were differentially expressed in the DKO
mice only (Fig. 6B). Of these, 33 genes were common to the 80
genes that were identified using the K562 ChIP-seq data (Table S2).
Importantly, this subset included Gata1, Runx1, Zfpm1 and
erythroid differentiation genes Gypc, Hmbs and Slc4a1.
Finally, de novo motif discovery of the shared SCL- and LYL1-
bound sequences identified significant enrichment for GATA1motifs
(Fig. 6C), supporting our hypothesis that either SCL or
LYL1 functions in concert with GATA1 to regulate erythroid
growth and differentiation. This was further confirmed by targeted
motif scanning (Fig. 6D), which verified enrichment for GATA1
(42% of bound sequences), and also identified the relative
overrepresentation of LYL1/SCL (32% of bound sequences) and
RUNX1 (26% of bound sequences) motifs. Of note, the majority
of these sites were also bound by GATA1 with or without
RUNX1 (Fig. 6E). Similarly, the 114 differentially expressed Scl
targets identified in mouse hematopoietic progenitors (Fig. 6B) were
also frequently bound by Lmo2 (97/114), Gata1 (58/114) and Runx1
Fig. 6. Integration of ChIP-seq and
RNA-seq data. (A) Venn diagram showing
overlap of differentially expressed genes
for ESclcKO, Lyl1KO and DKO cells with
mouse homologs of the common SCL- and
LYL1-binding sites identified in K562 cells.
(B) Venn diagram showing overlap of
differentially expressed genes with the
genes nearest to Scl-binding sites in mouse
hematopoietic progenitors. (C) De novo
motif discovery of the 80 K562 ChIP-seq
binding sites has identified significant
enrichment for the GATA1 motif.
(D) Targeted motif scanning has identified
GATA, LYL1/SCL and RUNX1 motifs.
(E) Intersection of LYL1, SCL, GATA1 and
RUNX1 K562 ChIP-seq binding sites.
(F) Venn diagram showing overlap of the
114 Scl-binding sites that have been
identified in mouse hematopoietic
progenitors with Gata1-, Lmo2- and
Runx1-binding sites.
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(51/114) (Fig. 6F). Overall, these results suggest that shared Scl- and
Lyl1-binding targets are also targets of Gata1, Lmo2 and Runx1.
DISCUSSION
Functional genetic redundancy is an evolutionary process that limits
the impact of mutations on key developmental programs and
enables a finer degree of control (Kafri et al., 2009). Robust
primitive erythropoiesis is essential for the viability of the rapidly
developing embryo and, in this context, we show that either Scl or
Lyl1, two closely related bHLH TFs, are capable of maintaining
primitive erythropoiesis. However, Lyl1KO embryos with a
markedly reduced expression of Scl die at E10.5 because of the
loss of primitive erythropoiesis. An integrated approach using
expression analyses and ChIP shows that this functional redundancy
is most likely explained by sharing common partner proteins and
target genes including the master erythroid regulator Gata1.
We have previously shown that deletion of Scl in adult HSCs
leads to a transient loss of erythroid progenitors that recovers within
a few weeks (Hall et al., 2005). We postulated that Lyl1 was the TF
that maintained erythropoiesis in the absence of Scl. To examine
the functional role of Scl in primitive erythropoiesis, we used an
erythroid-specific Cre transgenic mouse strain that can delete lox-
P-flanked alleles in primitive erythroid cells from E8.5 (Drogat
et al., 2010). The RNA-seq analyses performed at E9.5
demonstrated 10% residual Scl expression that was sufficient to
allow embryonic development to adulthood. However, in the
absence of Lyl1, this markedly reduced expression of Scl was
unable to maintain primitive erythropoiesis, leading to the death of
all embryos by E10-E11, a time in development that relies upon
primitive erythropoiesis (Palis, 2014). There is, therefore, functional
redundancy of Scl and Lyl1 for murine primitive erythropoiesis.
Given that the Cre transgene is not active until E8.5, our
experiments do not address the functional redundancy of Scl and
Lyl1 for initiation of primitive erythropoiesis.
In light of our results, previous conclusions that Scl is essential
for primitive erythropoiesis should be reconsidered. Deletion of
Sclwith the Tie2Cre transgene led to embryonic death with systemic
edema and hemorrhage at around E13.5 (Schlaeger et al., 2005).
Primitive erythroid cells showed a delay in maturation, leading
to the conclusion that defects in erythropoiesis contributed to
embryonic death. However, our results suggest that the loss of Scl in
other lineages in which Tie2Cre is active, such as megakaryocytes
and endothelium, might explain the embryonic death of Tie2Cre;
SclΔ/Δ mice. A second study examined the phenotype of Scl knock-
in mice (SclRER), which carry a germline mutation that prevents
DNA binding (Kassouf et al., 2008). These mice had defects of both
primitive and definitive erythropoiesis, with the majority (75%) of
embryos dying between E14.5 and E17.5. This phenotype led to the
conclusion that Scl DNA-binding was crucial for erythropoiesis.
However, an alternate explanation for the embryonic lethality of the
SclRER mice is a dominant-negative effect of the Scl DNA-binding
mutant, which retains the ability to form a multimeric complex and
therefore compete with Lyl1. A competitive model between the Scl
DNA-binding mutant and Lyl1 could explain the later death of
SclRER embryos and the partial penetrance in which 25% survived to
adulthood with a mild anemia similar to ESclcKO mice. The ability
of Lyl1 to bind a small subset (10%) of Scl target genes may also
explain the ChIP-seq analyses of SclRER fetal livers, in which 20%
of Scl-binding targets were retained in the absence of Scl DNA
binding (Kassouf et al., 2010). In support of this hypothesis, we
found significant overlap of common Scl/Lyl1-binding sites with
the sites that can be bound by the Scl DNA-binding mutant that were
identified in SclRER fetal livers (Table S3). Taken together, our
results suggest that Scl is not essential for the maintenance of
primitive erythropoiesis, as was previously thought.
The early death of DKO mice indicates that Lyl1 is the TF that is
responsible for survival of the ESclcKO mice. Analysis of single-
cell data at E7.75 revealed that 170/187 (91%) of erythroid cells
express Scl and/or Lyl1 (Fig. 1A). This provides pools of cells that
could explain the ongoing erythropoiesis in the absence of either
factor at E10.5 into adulthood. The embryonic lethality of Lyl1KO
mice that show markedly reduced Scl expression suggests that
the minor cell population that lacks Scl and Lyl1 at E7.75 is either
transient, insufficient to maintain survival at E10.5 or is an
experimental artefact of single-cell technologies. The likely
mechanism for in utero death of DKO embryos is transcriptional
loss ofGata1, asGata1 null embryos die at a similar developmental
stage (Fujiwara et al., 1996). Reduced expression of Gata1 in DKO
embryos cannot be explained by reduced numbers of erythroid cells
because gene expression profiling was performed before significant
loss of primitive erythropoiesis. Studies of embryonic stem cells
shows an important role for Gata1 in erythroid survival and
maturation (Weiss and Orkin, 1995). Our analyses of E9.5 DKO
cells also suggests a role for Scl/Lyl1 in cell proliferation.
We identified 80 other direct target genes shared by Scl and Lyl1
that may also contribute to the embryonic lethality. However, the
loss of many of these erythroid genes, including Klf1 and Zfpm1, is
likely due to loss of the Scl-Gata1 and Lyl1-Gata1 complexes, given
that the majority of common Scl/Lyl1-binding sites also bindGata1
(Fig. 6C,D). The common binding sites for SCL, LYL1 and GATA1
is consistent with the presence of a multimeric transcriptional
complex, although detailed analyses of the LYL1 complex in
erythroid cells has not yet been reported. Given that Gata1 functions
within a multiprotein complex that contains Scl, overexpression
of Gata1 alone would not be sufficient to rescue the defects in
DKO cells.
In summary, we have demonstrated that Lyl1 can compensate
for the loss of Scl expression during primitive erythropoiesis, with
functional redundancy due to shared DNA-binding targets
including the crucial erythroid TF gene Gata1.
MATERIALS AND METHODS
Mice
Mice with homozygous lox-P-targeted Scl allele (SclcKO) (Hall et al., 2003)
were crossed with erythropoietin receptor Cre-recombinase (EpoRCre) mice
(Drogat et al., 2010) to generate EpoRCreSclcKOmice with lineage-specific
deletion of Scl. These mice were then crossed with homozygous
Lyl1 knockout mice (Lyl1KO) (Capron et al., 2006) to generate
EpoRCreSclcKOLyl1KO mice, with both genes deleted in RBCs. The
Animal Ethics Committee of the Alfred Medical Research and Education
Precinct approved all animal experiments.
Blood counts
Mice were bled by puncturing the submandibular vein. Blood was then
placed into Sarstedt Microvette collection tubes containing EDTA and full
blood counts were performed on a Drew Scientific Hemavet system.
Embryo dissection and yolk sac collection
Embryos were collected at E9.5 to E15.5 and placed in PBS at room
temperature and dissected with fine forceps under a dissecting microscope
(Nikon SMZ1500). Photographs of embryos were taken with a Zeiss
AxioCamMRC5 camera. Yolk sac cells were obtained by digestion at 37°C
for 30 min in PBS with 7% fetal calf serum (FCS) and 1% penicillin/
streptomycin collagenase/dispase (Sigma-Aldrich). Ice-cold PBS with 7%
FCS and 1 mM EDTA solution was added to stop the digestion and the cells
were then spun at 1500 rpm (300 g) for 5 min at 4°C. The yolk sac pellet was
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re-suspended in ice-cold PBSwith 7% FCS and 1 mMEDTA, homogenized
with vigorous pipetting and then filtered through a 40 μm nylon strainer.
Samples were then used for cytospin, benzidine staining, RNA extraction
and flow cytometry.
Flow cytometry
Flow cytometry and cell sorting was performed as previously described
(Tremblay et al., 2010). Briefly 2×106 bone marrow cells were stained using
BD Pharmingen antibodies against mouse CD71 (C2 ; 553266) and Ter119
(Ter-119; 561033) and BioLegend antibodies against mouse CD105 (Mj7/18;
120412) and CD150 (TC15-12F12.2; 115904). All antibodies were used at
1:500 except CD150 which was used at 1:100. Dead cells were excluded
using propidium iodide staining. Cell sorting was performed using
FACSAria (BD Biosciences) and FACS analysis was performed using
CantoII, LSRII and LSR-Fortessa (BD Biosciences). Results were analyzed
using DIVA and FlowJo software.
RNA extraction and qPCR
RNAwas extracted using Trizol and the RNAeasy mini kit (Qiagen). RNA
(1 μg) was used to make cDNAwith the Transcriptor First Strand cDNA kit
(Roche). qPCR was performed on a Lightcycler 480 II machine (Roche).
Results were standardized to expression of the Hprt housekeeping gene.
RNA-seq
Total RNA from E9.5 yolk sacs was extracted for mRNA sequencing using
Illumina HiSeq2500. Library preparation and sequencing was performed by
Micromon (Monash University). Data was analyzed using an in-house
developed pipeline, RNASik (v1.4.7) (monashbioinformaticsplatform.
github.io/RNAsik-pipe). Raw reads were aligned using STAR (v2.5.2b)
(Dobin et al., 2013) with GRCm38 reference genome from ENSEMBL.
Gene counts were generated using feature counts in subread (v1.5.2)
(Liao et al., 2014) with GRCm38.87 gene annotation from ENSEMBL.
Differential expression analysis was performed in Degust (degust.erc.
monash.edu) using LIMMA/edgeR/Voom. Public single-cell RNA-seq
data: raw read count single-cell data were extracted from a recent study
(Scialdone et al., 2016; gastrulation.stemcells.cam.ac.uk/scialdone2016)
and analyzed using LIMMA(v3.32.2)/edgeR (v3.18.1)/Voom libraries in
R Bioconductor v3.5 (bioconductor.org). Raw read counts were Voom-
transformed into counts per million.
ChIP-seq analysis
The raw ChIP-seq reads were filtered for adapter contamination and low
quality scores, and we also excluded reads in which more than 10% of bases
were unknown. The following K562 ChIP-seq datasets were publicly
available from GEO (SCL, GSE31477; RUNX1, GSE24777; GATA1,
GSE70482). The ChIP-seq data for mouse hematopoietic progenitors was
obtained from GSE69101 (Goode et al., 2016). Data processing was
performed as previously described (Beck et al., 2013; Chacon et al., 2014;
Wilson et al., 2010). In brief, reads were aligned to the human genome
(hg19) using the software package BWAwith standard parameters, resulting
in 13,394,203 mapped reads for LYL1, 29,426,999 mapped reads for SCL,
8,033,900 mapped reads for RUNX1, 22,622,534 mapped reads for
GATA1. Three publicly available peak finding programs, MACS (Feng
et al., 2012), findPeaks (HOMER) (Heinz et al., 2010) and SPP
(Kharchenko et al., 2008), were used to call peaks. Peaks called by at
least two algorithms were identified as high-confidence binding sites for
downstream analysis.De novomotif discovery was performed usingMEME
(Bailey and Elkan, 1994). High-confidence binding regions were assigned
as regulatory regions to at most two genes using annotations provided by the
GREAT analysis package (McLean et al., 2010). Homology information for
human and mouse was downloaded from MGI (Blake et al., 2017) and we
found that 16,824 human genes were associated with 17,196 mouse
homologs. 1575 LYL1 and SCL target genes in K562 cells were mapped
1403 mouse homologs. RUNX1, GATA1 and TAL1 motifs were
downloaded from the JASPAR database and occurrence searched using
the FIMO software from the MEME suite. A bootstrapping approach was
used to address the significance of combinatorial binding events between the
TFs for all possible binding patterns. A lower estimate of 80,000 binding
sites available for TF binding (Tijssen et al., 2011; Wilson et al., 2010) was
used to estimate the background distribution of combinatorial binding
events. The standardized z-score metric was then used to express the
deviation of the combinatorial binding events from the expected mean
(normalized by the standard deviation) of the background distribution (i.e. a
positive z-score indicates an overlap more likely than random chance; a
higher z-score indicates a more significant overlap).
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